AI trial to tackle breast cancer launched

Nearly 700,000 women across the country will take part in a trial to test how AI tools can be used to catch breast cancer cases earlier, the DHSC has announced.

© National Cancer Institute/Unsplash

© National Cancer Institute/Unsplash

Under the plans, 30 testing sites across the country will be enhanced with the latest digital AI technologies, ready to invite women already booked in for routine screenings on the NHS to take part.

The technology will assist radiologists, screening patients to identify changes in breast tissue that show possible signs of cancer and referred for further investigations if required.

Currently two specialists are needed per mammogram screening, but this technology will enable just one to complete the same mammogram screening process safely and efficiently.

The EDITH trial is backed by £11m of government support via the National Institute for Health and Care Research (NIHR).

Prof Lucy Chappell, chief scientific adviser at the DHSC and chief executive of the NIHR, said: ‘This landmark trial could lead to a significant step forward in the early detection of breast cancer, offering women faster, more accurate diagnoses when it matters most. 

‘It is another example of how NIHR research, shaped and funded by the public, is crucial for rigorously testing world-leading new technologies, such as AI, that can potentially save lives while reducing the burden on the NHS.'

Suffolk and North East Essex ICB launches AI cancer detection pilot

Suffolk and North East Essex ICB launches AI cancer detection pilot

By Liz Wells 19 March 2026

Suffolk and North East Essex ICB has launched a pilot using AI to help identify people at risk of upper gastrointestinal cancers in north east Essex.

Moving data where it's needed

By Lee Peart 18 March 2026

Marlen Suller, managing director for EMEA Clinical Diagnostics at Magentus, says the National Cancer Plan cannot succeed without connected data infrastructur...

Designing AI regulation that helps the NHS adopt safely, confidently and at pace

12 March 2026

Dr Hatim Abdulhussein, chief executive of Health Innovation Kent Surrey Sussex, explores why when it comes to AI regulation, the question is not whether to e...


Popular articles by Liz Wells